にゃんごう＆いがさんのEBMerな夜

第100回放送　2025/3/30

【にゃんごう：2型糖尿病における年齢と性別による治療効果の違い】

Hanlon P, Butterly E, Wei L, Wightman H, Almazam SAM, Alsallumi K, Crowther J, McChrystal R, Rennison H, Hughes K, Lewsey J, Lindsay R, McGurnaghan S, Petrie J, Tomlinson LA, Wild S, Adler A, Sattar N, Phillippo DM, Dias S, Welton NJ, McAllister DA.

Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.

JAMA. 2025 Mar 25;333(12):1062-1073. doi: 10.1001/jama.2024.27402.

PMID: 39899304; PMCID: PMC11791772.

https://jamanetwork.com/journals/jama/fullarticle/2829848

【いがさん：アルコール使用障害患者における週1回投与のセマグルチド】

Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, Tow AC, Dermody SS, Prince MA, Jordan R, McKee SA, Fletcher PJ, Claus ED, Klein KR.

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.

JAMA Psychiatry. 2025 Feb 12:e244789. doi: 10.1001/jamapsychiatry.2024.4789. Epub ahead of print.

PMID: 39937469; PMCID: PMC11822619.

https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2829811

リスナーアンケートにご協力下さい！！

https://goo.gl/forms/5AsPilK7QnB9VrmX2